key: cord-0907182-sqeu3e9c
authors: Armiñanzas, Carlos; Arnaiz de las Revillas, Francisco; Gutiérrez Cuadra, Manuel; Arnaiz, Ana; Fernández Sampedro, Marta; González-Rico, Claudia; Ferrer, Diego; Mora, Víctor; Suberviola, Borja; Latorre, Maite; Calvo, Jorge; Olmos, José Manuel; Cifrián, José Manuel; Fariñas, María Carmen
title: USEFULNESS OF THE COVID-GRAM AND CURB-65 SCORES FOR PREDICTING SEVERITY IN PATIENTS WITH COVID-19
date: 2021-05-24
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.05.048
sha: eee7c868f27ecae7eb749ac4ca17232f071a68df
doc_id: 907182
cord_uid: sqeu3e9c

PURPOSE: We studied the usefulness of COVID-GRAM and CURB-65 scores as predictors of severity of SARS-CoV-2 infection in Caucasian patients. METHODS: Retrospective observational study including all adults with SARS-CoV-2 infection admitted to our hospital from February to May 2020. Patients were stratified according to COVID-GRAM and CURB-65 scores as low-medium or high risk of critical illness. Univariate analysis, multivariate logistic regression models, receiver-operator-characteristics curve, and area under the curve were calculated. RESULTS: We included 523 patients (51.8% male; 65.63 years ([SD: 17.89 years]), of whom 110 (21%) presented critical illness (ICU admission: 10.3%; 30-day mortality: 13.8%). According to COVID-GRAM score, 122 (23.33%) patients were classified as high risk; 197 (37.7%) presented a CURB-65 ≥ 2. A significantly greater proportion of patients with critical illness had a high COVID-GRAM score (64.5% vs 30.5%; p < 0.001). COVID-GRAM score emerged as an independent predictor of critical illness (OR, 9.40; 95% CI, 5.51-16.04; p < 0.001), showing an AUC = 0.779. A high COVID-GRAM score showed an AUC = 0.88 for prediction of 30-day mortality, while a CURB-65 ≥ 2 showed an AUC = 0.83. CONCLUSIONS: The COVID-GRAM score may be a useful tool for evaluating the risk of critical illness in Caucasian patients with SARS-CoV-2 infection. CURB-65 score could be considered as an alternative.

In December 2019, the novel coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in the city of Wuhan, China (Sohrabi et al., 2020) . Spreading around the world in the early part of 2020, it is now considered pandemic, with more than 45 million cases worldwide and more than 1,100,000 deaths by the end of October, according to the World Health Organization (who.int/emergencies, 2020).

Clinical presentation of COVID-19 typically includes fever and pulmonary involvement (Shi et al., 2020; Lai et al., 2020) , although almost any organ can be affected (Stokes et al., 2020) . In some patients, the disease quickly progresses to respiratory failure and even death (Garcia-Alamino et al., 2020) . The proportion of patients becoming critically ill reaches almost 25% (Ye et al., 2020; Petrilli et al., 2020) , and the case fatality ratio has been between less than 0.1% and over 25% (Li et al., 2020) . Different risk factors have been associated with severe disease and mortality, including age and male sex (Hur et al., 2020; Michelozzi et al., 2020 ), various comorbidities (Alqahtani et al., 2020 Zhao et al., 2020) , and some clinical laboratory and radiological findings (Zhang JJY et al., 2020; Cappabianca et al., 2020) .

Although only a small percentage of patients require admission to intensive care unit (ICU) or mechanical ventilation, the COVID-19 population overwhelmed healthcare systems all over the world during the first wave of the pandemic, and threatens to continue to do so. Some tools have been proposed to evaluate the J o u r n a l P r e -p r o o f risk of severe infection, in order to provide the most appropriate care and optimize limited resources (Yee et al., 2020; Zhou et al., 2020; Sprung et al., 2020; Ryan et al., 2020; Altschul et al., 2020) . The COVID-GRAM score, validated to predict the risk of critical illness or death in Chinese population, was one of the first published (Liang et al., 2020) . The CURB-65 score (Lim et al., 2003) has been proposed in our country as the reference prognostic tool for SARS-COV-2 pneumonia (mscbs.gob.es, 2020).

The aim of our study was to evaluate if the COVID-GRAM score could also be used as a prognostic score at the time of hospital admission in Caucasian patients with SARS-CoV-2 infection, and to compare its accuracy with the CURB-65 score.

This retrospective observational cohort study was conducted from February 27th

to May 25th, 2020. All adults with laboratory-confirmed SARS-CoV-2 infection admitted to a tertiary university hospital were included.

The following exclusion criteria were applied: (a) age <18 years; (b) patients who had been previously included in our study.

All patients received standard-of-care treatment according to the local protocol.

The following patient characteristics at hospital admission were collected: age, and WHO score ≥ 5 (who.int/blueprint, 2020).

All data were analysed and processed on SPSS software. Main epidemiological and clinical characteristics of patients, laboratory and radiological findings, and comparisons between patients with and without critical illness are shown in tables 1, 2 and 3.

One hundred and twenty-two (23.33%) patients were classified as high risk according to their COVID-GRAM score, while 197 (37.7%) patients presented a CURB-65 score ≥ 2.

The proportion of patients with a high COVID-GRAM score was significantly greater in the group of patients with critical illness compared to those without critical illness (64.5% vs 30.5, respectively; p<0.001) ( 1B) .

We evaluated the accuracy of the COVID-GRAM score for predicting 30-day mortality. Among patients with a high COVID-GRAM score, mortality was 10.7%

(56 patients). We found that a high COVID-GRAM score showed a sensitivity of 77%, a specificity of 85%, a PPV of 46%, and a NPV of 96% (table 4) When the group of patients with complete data were analysed separately, a high COVID-GRAM score also emerged as an independent predictor of mortality (OR, 24,52; 95% CI, 8.41-71.54; p<0.001).

Among patients with a high CURB-65 score, mortality was 11.85% (62 patients).

A CURB-65 score ≥ 2 showed a sensitivity of 86%, a specificity of 70%, a PPV of 31%, and a NPV of 97% (table 4) , and an AUC of 0.83 ( fig. 1D) 68.5% for CURB-65 score < 2; p=0.322).

To our knowledge, this is the first study to analyse the usefulness of the COVID-GRAM score in a non-Chinese population. A high COVID-GRAM score at admission emerged as an independent predictor of critical illness, showing good sensitivity, specificity and, especially, negative predictive value. ROC curves showed good accuracy in predicting critical illness.

Accuracy was even higher in the original study of Liang (Liang et al., 2020) , perhaps influenced by the higher age and comorbidities of our patients. When the COVID-GRAM score was applied for predicting mortality, higher NPV and ROC curve values were obtained.

Interestingly, the accuracy of the CURB-65 score in predicting mortality was quite similar to that of the COVID-GRAM score. Although the AUC was slightly lower, the CURB-65 score showed a good NPV, and its simplicity of use makes it particularly attractive for routine clinical practice in COVID-19 patients, especially when quick decisions must be made, such as occurs in emergency departments.

Our results on the accuracy of CURB-65 for mortality of patients with SARS-CoV-This study has some limitations. First, its retrospective approach means that some variables were unknown from the COVID-GRAM and CURB-65 scores at admission. We have assigned all unknown variables a value of normal, in order to not overestimate the results of both scores. Secondly, all study participants were seen in the same hospital, and there may be differences among populations, even though we observed similar patient characteristics as in other

European and North American studies (Richardson et al., 2020; Suleyman et al., 2020; Giacomelli et al., 2020; Guisado-Vasco et al., 2020) . Finally, since all patients in our study were hospitalized, it is impossible to conclude if patients with a low risk of critical illness and mortality according to COVID-GRAM and CURB-65 could be safely discharged.

In summary, the COVID-GRAM score may be an useful tool for identifying

Caucasian patients with SARS-CoV-2 infection and a low risk of critical illness and mortality. The CURB-65 score could be a good alternative, especially in situations of care overload where decisions must be made quickly. Further studies are needed to confirm if those patients could be safely discharged and monitored on an outpatient basis. J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f 

CRP: C-reactive protein, SD: standard deviation